Chaired by Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche, the 7th Annual Partnership Opportunities in Drug Delivery (PODD) event will take place on October 19-20, 2017 at the Marriott Copley Place in Boston.
This annual conference is designed with three purposes:
1. To present a strategic level program for pharma and biotech business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
3. To offer ample networking time, facilities and services for one-on-one meetings to establish new business contacts and enhance existing ones.
Choose from 3 tracks (6 sessions) covering a broad range of enabling delivery technologies:
Track 1A: Injectable Technologies, chaired by Matthew Burke, PhD, Head of Drug Delivery, GSK
Track 2A: Oral Delivery Technologies, chaired by René Holm, PhD, Head and Scientific Director, Drug Product Development, Liquids and Parenterals, Janssen
Track 3A: Device Technologies, chaired by Mathias Romacker, Senior Director, Device Strategy, Pfizer
Track 1B: Injectable Technologies, chaired by Ulrich Bruggemann, Head Academics and Innovation, Global Medical Devices Development, Sanofi US
Track 2B: Non-Injectable Technologies: Transdermal and Transmucosal, chaired by Robert Saklatvala, PhD, Director, Discovery Pharmaceutical Sciences, Merck
Track 3B: Device Technologies, chaired by Justin Wright, PhD, VP, Drug Delivery Innovation, DDRandD Technology, Eli Lilly and Co
Learn about sponsorship and exhibition opportunities. Contact Customer Service at service@tcfllc.org or call 646-350-2580.
This annual conference is designed with three purposes:
1. To present a strategic level program for pharma and biotech business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
3. To offer ample networking time, facilities and services for one-on-one meetings to establish new business contacts and enhance existing ones.
Choose from 3 tracks (6 sessions) covering a broad range of enabling delivery technologies:
Track 1A: Injectable Technologies, chaired by Matthew Burke, PhD, Head of Drug Delivery, GSK
Track 2A: Oral Delivery Technologies, chaired by René Holm, PhD, Head and Scientific Director, Drug Product Development, Liquids and Parenterals, Janssen
Track 3A: Device Technologies, chaired by Mathias Romacker, Senior Director, Device Strategy, Pfizer
Track 1B: Injectable Technologies, chaired by Ulrich Bruggemann, Head Academics and Innovation, Global Medical Devices Development, Sanofi US
Track 2B: Non-Injectable Technologies: Transdermal and Transmucosal, chaired by Robert Saklatvala, PhD, Director, Discovery Pharmaceutical Sciences, Merck
Track 3B: Device Technologies, chaired by Justin Wright, PhD, VP, Drug Delivery Innovation, DDRandD Technology, Eli Lilly and Co
Learn about sponsorship and exhibition opportunities. Contact Customer Service at service@tcfllc.org or call 646-350-2580.
